source
- Goa Therapeutics launches with $15.5M funding to develop fast-acting alcohol sobering drugGoa Therapeutics announced its launch, backed by $15.5 million raised mainly from individual industry leaders, and has filed for an initial public offering that could raise up to $75 million. The…
- North Immunology to go public via reverse merger, targeting eczema with bispecific antibodyNorth Immunology, a private biotech incubated by ADAR1 Capital Management, announced it will become a public company through a reverse merger with Nasdaq‑listed Aethlon Medical. The merged entity…